ClariTrial | Search Clinical Trials

Explore/Cancer

Status

Phase

143,661 results for “Cancer”

Page 1 of 9578

Withdrawn

Collection of Retrospective (Archival) Samples and Prospective Collection of Surplus Tissue and Blood Samples

N/ACancer

Global BioClinical01 site · United StatesCompletes Dec 2022

Compare CT.gov Full analysis →

Completed

Combined Oral and Parenteral Nutritional Therapy After Gastrectomy for Gastric Cancer

N/AGastric Cancer (GC)Malnutitrion

Oral Nutritional SupplementationParenteral NutritionStandard Postoperative Nutritional Care

Kyo Young Song55 participants1 site · South KoreaCompletes May 2024

Compare CT.gov Full analysis →

Recruiting

A Pilot Study of Monitoring Insulin Levels and Treating Hyperinsulinemia and Hyperglycemia With Pioglitazone in Patients Treated With Alpelisib for Metastatic Breast Cancer.

Early Phase 1Metastatic Breast CancerHyperinsulinismHyperglycemia Drug Induced

Pioglitazone

Rambam Health Care Campus30 participants1 site · IsraelCompletes Dec 2026

Compare CT.gov Full analysis →

Completed

Radiologically Guided Biopsies of mCRPC

N/AProstate Cancer

Image-Guided Biopsies

University of California, San Francisco256 participants5 sites · United States, CanadaCompletes Jan 2020

Compare CT.gov Full analysis →

UNKNOWN

Registry on NEN Patients and COVID-19

N/ANeuroendocrine TumorsCOVID-19

European Institute of Oncology50 participants1 site · ItalyCompletes Dec 2023

Compare CT.gov Full analysis →

Recruiting

Comparing SingLe- Vs Multi-Fraction Spine STereotActic Radiosurgery in Spinal Metastases

Phase 3Spinal Metastases

Single-fraction spine SRSMulti-fraction spine SRS

Stanford University274 participants1 site · United StatesCompletes Dec 2028

Compare CT.gov Full analysis →

UNKNOWN

68Ga-BNU-PSMA PET/CT in Patients With Various Types of Cancer

Early Phase 1TumorPositron-Emission TomographyMetastasis

68Ga-BNU-PSMA

First Affiliated Hospital of Fujian Medical University100 participants1 site · ChinaCompletes Dec 2022

Compare CT.gov Full analysis →

UNKNOWN

DCV in the Treatment of Recurrence and Refractory Childhood Solid Tumors

Phase 1Unrecognized Condition

pegylated liposomal doxorubicin, cyclophosphamide, vincristine,

Sun Yat-sen University21 participantsCompletes Aug 2020

Compare CT.gov Full analysis →

Terminated

Results posted

GSK1120212+GSK2141795 for Cervical Cancer

Phase 2Cervical Cancer

GSK1120212 (trametinib)GSK2141795

Dana-Farber Cancer Institute14 participants1 site · United StatesCompletes Nov 2017

Compare CT.gov Full analysis →

Completed

Defining the Extent and Grade of Prostate Cancer Using Dynamic Contrast Enhanced Diffusion Weighted and BOLD MRI

N/AProstate Cancer

MRI Prostate

University Health Network, Toronto31 participants1 site · CanadaCompletes Feb 2008

Compare CT.gov Full analysis →

UNKNOWN

H002 in Patients With EGFR Mutation Locally Advanced or Metastatic NSCLC

Phase 1Phase 2Non-small Cell Lung Cancer

H002 capsule

RedCloud Bio76 participants8 sites · ChinaCompletes Feb 2025

Compare CT.gov Full analysis →

UNKNOWN

A Biomarker Study for Predicting the Efficacy of Neoadjuvant Sintilimab Plus SOX for Gastric Adenocarcinoma.

Phase 2Gastric Cancer

Sintilimab

The First Affiliated Hospital with Nanjing Medical University90 participantsCompletes Sep 2023

Compare CT.gov Full analysis →

Recruiting

68Ga-HA-DOTATATE Imaging of Suspected Somatostatin Receptor Positive Tumors

Phase 2Neuroendocrine Tumors

68Ga-HA-DOTATATE

University of Alberta600 participants1 site · CanadaCompletes Aug 2027

Compare CT.gov Full analysis →

Completed

Study of Epidermal Growth Factor on Oral Mucositis Induced by Intensive Chemotherapy for Hematologic Malignancies

Phase 2Oral Mucositis

rhEGF + povidone iodine, chlorhexidine, & nystatinPlacebo + povidone iodine, chlorhexidine, & nystatin

Seoul National University Hospital138 participants1 site · South KoreaCompletes Oct 2014

Compare CT.gov Full analysis →

Terminated

Dose Finding Study of TNO155 in Adult Patients With Advanced Solid Tumors

Phase 1Advanced EGFR Mutant Non Small Cell LungCancer (NSCLC)KRAS G12-mutant NSCLCEsophageal Squamous Cell Cancer (SCC)

TNO155TNO155 in combination with EGF816 (nazartinib)

Novartis Pharmaceuticals227 participants18 sites · United States, Canada, ItalyCompletes Jul 2025

Compare CT.gov Full analysis →

1–15 of 143,661

Explore/Cancer

Status

Phase

143,661 results for “Cancer”

Page 1 of 9578

Withdrawn

Collection of Retrospective (Archival) Samples and Prospective Collection of Surplus Tissue and Blood Samples

N/ACancer

Global BioClinical01 site · United StatesCompletes Dec 2022

Compare CT.gov Full analysis →

Completed

Combined Oral and Parenteral Nutritional Therapy After Gastrectomy for Gastric Cancer

N/AGastric Cancer (GC)Malnutitrion

Oral Nutritional SupplementationParenteral NutritionStandard Postoperative Nutritional Care

Kyo Young Song55 participants1 site · South KoreaCompletes May 2024

Compare CT.gov Full analysis →

Recruiting

A Pilot Study of Monitoring Insulin Levels and Treating Hyperinsulinemia and Hyperglycemia With Pioglitazone in Patients Treated With Alpelisib for Metastatic Breast Cancer.

Early Phase 1Metastatic Breast CancerHyperinsulinismHyperglycemia Drug Induced

Pioglitazone

Rambam Health Care Campus30 participants1 site · IsraelCompletes Dec 2026

Compare CT.gov Full analysis →

Completed

Radiologically Guided Biopsies of mCRPC

N/AProstate Cancer

Image-Guided Biopsies

University of California, San Francisco256 participants5 sites · United States, CanadaCompletes Jan 2020

Compare CT.gov Full analysis →

UNKNOWN

Registry on NEN Patients and COVID-19

N/ANeuroendocrine TumorsCOVID-19

European Institute of Oncology50 participants1 site · ItalyCompletes Dec 2023

Compare CT.gov Full analysis →

Recruiting

Comparing SingLe- Vs Multi-Fraction Spine STereotActic Radiosurgery in Spinal Metastases

Phase 3Spinal Metastases

Single-fraction spine SRSMulti-fraction spine SRS

Stanford University274 participants1 site · United StatesCompletes Dec 2028

Compare CT.gov Full analysis →

UNKNOWN

68Ga-BNU-PSMA PET/CT in Patients With Various Types of Cancer

Early Phase 1TumorPositron-Emission TomographyMetastasis

68Ga-BNU-PSMA

First Affiliated Hospital of Fujian Medical University100 participants1 site · ChinaCompletes Dec 2022

Compare CT.gov Full analysis →

UNKNOWN

DCV in the Treatment of Recurrence and Refractory Childhood Solid Tumors

Phase 1Unrecognized Condition

pegylated liposomal doxorubicin, cyclophosphamide, vincristine,

Sun Yat-sen University21 participantsCompletes Aug 2020

Compare CT.gov Full analysis →

Terminated

Results posted

GSK1120212+GSK2141795 for Cervical Cancer

Phase 2Cervical Cancer

GSK1120212 (trametinib)GSK2141795

Dana-Farber Cancer Institute14 participants1 site · United StatesCompletes Nov 2017

Compare CT.gov Full analysis →

Completed

Defining the Extent and Grade of Prostate Cancer Using Dynamic Contrast Enhanced Diffusion Weighted and BOLD MRI

N/AProstate Cancer

MRI Prostate

University Health Network, Toronto31 participants1 site · CanadaCompletes Feb 2008

Compare CT.gov Full analysis →

UNKNOWN

H002 in Patients With EGFR Mutation Locally Advanced or Metastatic NSCLC

Phase 1Phase 2Non-small Cell Lung Cancer

H002 capsule

RedCloud Bio76 participants8 sites · ChinaCompletes Feb 2025

Compare CT.gov Full analysis →

UNKNOWN

A Biomarker Study for Predicting the Efficacy of Neoadjuvant Sintilimab Plus SOX for Gastric Adenocarcinoma.

Phase 2Gastric Cancer

Sintilimab

The First Affiliated Hospital with Nanjing Medical University90 participantsCompletes Sep 2023

Compare CT.gov Full analysis →

Recruiting

68Ga-HA-DOTATATE Imaging of Suspected Somatostatin Receptor Positive Tumors

Phase 2Neuroendocrine Tumors

68Ga-HA-DOTATATE

University of Alberta600 participants1 site · CanadaCompletes Aug 2027

Compare CT.gov Full analysis →

Completed

Study of Epidermal Growth Factor on Oral Mucositis Induced by Intensive Chemotherapy for Hematologic Malignancies

Phase 2Oral Mucositis

rhEGF + povidone iodine, chlorhexidine, & nystatinPlacebo + povidone iodine, chlorhexidine, & nystatin

Seoul National University Hospital138 participants1 site · South KoreaCompletes Oct 2014

Compare CT.gov Full analysis →

Terminated

Dose Finding Study of TNO155 in Adult Patients With Advanced Solid Tumors

Phase 1Advanced EGFR Mutant Non Small Cell LungCancer (NSCLC)KRAS G12-mutant NSCLCEsophageal Squamous Cell Cancer (SCC)

TNO155TNO155 in combination with EGF816 (nazartinib)

Novartis Pharmaceuticals227 participants18 sites · United States, Canada, ItalyCompletes Jul 2025

Compare CT.gov Full analysis →

1–15 of 143,661